P158 PONDx Aragon: First spanish prospective study evaluating the impact of the 21-gene test on real praxis for N1 patients after RxPONDER results
2023 · The Breast · 0 citations
https://doi.org/10.1016/s0960-9776(23)00275-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
Ana Isabel Hoz Fernandez is an academic researcher from Biogipuzkoa Health Research Institute. The author has contributed to research in topics: Electronic Health Records Systems & Folate and B Vitamins Research & Esophageal Cancer Research and Treatment.
Click to start Chat